CN108420952A - Eliminating inflammation and expelling toxin diuresis soup - Google Patents
Eliminating inflammation and expelling toxin diuresis soup Download PDFInfo
- Publication number
- CN108420952A CN108420952A CN201710074894.2A CN201710074894A CN108420952A CN 108420952 A CN108420952 A CN 108420952A CN 201710074894 A CN201710074894 A CN 201710074894A CN 108420952 A CN108420952 A CN 108420952A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- diuresis
- expelling toxin
- grass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000004880 Polyuria Diseases 0.000 title claims abstract description 19
- 230000035619 diuresis Effects 0.000 title claims abstract description 19
- 206010061218 Inflammation Diseases 0.000 title claims abstract description 12
- 230000004054 inflammatory process Effects 0.000 title claims abstract description 12
- 235000014347 soups Nutrition 0.000 title claims abstract description 10
- 239000003053 toxin Substances 0.000 title claims abstract description 10
- 231100000765 toxin Toxicity 0.000 title claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 16
- 240000004064 Poterium sanguisorba Species 0.000 claims abstract description 12
- 235000008291 Poterium sanguisorba Nutrition 0.000 claims abstract description 12
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 12
- 244000001632 Acorus gramineus Species 0.000 claims abstract description 10
- 235000013073 Acorus gramineus Nutrition 0.000 claims abstract description 10
- 235000003805 Musa ABB Group Nutrition 0.000 claims abstract description 10
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 10
- 235000015266 Plantago major Nutrition 0.000 claims abstract description 10
- 241000522190 Desmodium Species 0.000 claims abstract description 9
- 244000241872 Lycium chinense Species 0.000 claims abstract description 9
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 9
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract description 9
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 9
- 240000001949 Taraxacum officinale Species 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 8
- 238000002386 leaching Methods 0.000 claims description 5
- 230000033228 biological regulation Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 238000004062 sedimentation Methods 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 17
- 208000019206 urinary tract infection Diseases 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 13
- 231100000614 poison Toxicity 0.000 abstract description 8
- 238000001816 cooling Methods 0.000 abstract description 7
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 6
- 239000003440 toxic substance Substances 0.000 abstract description 5
- 230000001684 chronic effect Effects 0.000 abstract description 4
- 208000002193 Pain Diseases 0.000 description 14
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 206010037660 Pyrexia Diseases 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 9
- AUNAUZZQBAIQFJ-UHFFFAOYSA-N 2,4,5-Trimethoxy-1-allylbenzene Chemical compound COC1=CC(OC)=C(OC)C=C1CC=C AUNAUZZQBAIQFJ-UHFFFAOYSA-N 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 210000003932 urinary bladder Anatomy 0.000 description 7
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 206010018612 Gonorrhoea Diseases 0.000 description 6
- 206010042674 Swelling Diseases 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 229930182478 glucoside Natural products 0.000 description 6
- -1 glucoside methyl esters Chemical class 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 241000245665 Taraxacum Species 0.000 description 5
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- WITLAWYGGVAFLU-UHFFFAOYSA-N 3-(6-methoxy-1,3-benzodioxol-5-yl)-8,8-dimethylpyrano[2,3-f]chromen-4-one Chemical compound C1=CC(C)(C)OC2=CC=C(C(C(C3=CC=4OCOC=4C=C3OC)=CO3)=O)C3=C21 WITLAWYGGVAFLU-UHFFFAOYSA-N 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 4
- RKFAZBXYICVSKP-AATRIKPKSA-N alpha-asarone Chemical compound COC1=CC(OC)=C(\C=C\C)C=C1OC RKFAZBXYICVSKP-AATRIKPKSA-N 0.000 description 4
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 4
- PTOJXIKSKSASRB-UHFFFAOYSA-O candicine Chemical compound C[N+](C)(C)CCC1=CC=C(O)C=C1 PTOJXIKSKSASRB-UHFFFAOYSA-O 0.000 description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 4
- 229960001231 choline Drugs 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- VHOCUJPBKOZGJD-UHFFFAOYSA-N triacontanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O VHOCUJPBKOZGJD-UHFFFAOYSA-N 0.000 description 4
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 3
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 3
- NLOAQXKIIGTTRE-UHFFFAOYSA-N Alisol-B-Monoacetat Natural products C=12CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CCC=1C(C)CC(OC(C)=O)C1OC1(C)C NLOAQXKIIGTTRE-UHFFFAOYSA-N 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 206010010071 Coma Diseases 0.000 description 3
- 206010011878 Deafness Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- BPLQKQKXWHCZSS-UHFFFAOYSA-N Elemicin Chemical compound COC1=CC(CC=C)=CC(OC)=C1OC BPLQKQKXWHCZSS-UHFFFAOYSA-N 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 208000004078 Snake Bites Diseases 0.000 description 3
- 208000037386 Typhoid Diseases 0.000 description 3
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 3
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 208000001786 gonorrhea Diseases 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 3
- 229940032091 stigmasterol Drugs 0.000 description 3
- 235000016831 stigmasterol Nutrition 0.000 description 3
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 3
- 230000010415 tropism Effects 0.000 description 3
- 201000008297 typhoid fever Diseases 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 2
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 2
- IAJBQAYHSQIQRE-UHFFFAOYSA-N 2,4,5-trimethoxybenzaldehyde Chemical compound COC1=CC(OC)=C(C=O)C=C1OC IAJBQAYHSQIQRE-UHFFFAOYSA-N 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- IWQURBSTAIRNAE-UHFFFAOYSA-N Alismoxide Chemical compound CC1(O)CCC(C(C)C)=CC2C(O)(C)CCC21 IWQURBSTAIRNAE-UHFFFAOYSA-N 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- DGDWCRWJRNMRKX-DILZHRMZSA-N Asperulosidic acid Chemical compound O([C@H]1[C@H]2[C@@H](C(=CO1)C(O)=O)[C@@H](O)C=C2COC(=O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGDWCRWJRNMRKX-DILZHRMZSA-N 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- MXTLAHSTUOXGQF-UHFFFAOYSA-O Jatrorrhizine Chemical compound COC1=CC=C2C=C3C(C=C(C(=C4)O)OC)=C4CC[N+]3=CC2=C1OC MXTLAHSTUOXGQF-UHFFFAOYSA-O 0.000 description 2
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 2
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 2
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 108010080154 N-benzoylphenylalanylphenylalinol acetate Proteins 0.000 description 2
- RBBVPNQTBKHOEQ-KKSFZXQISA-O Phellodendrine Chemical compound C1CC2=CC(OC)=C(O)C=C2[C@H]2[N@+]1(C)CC(C=C(C(=C1)O)OC)=C1C2 RBBVPNQTBKHOEQ-KKSFZXQISA-O 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 229930188824 alisol Natural products 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- DNAVOCNYHNNEQI-UHFFFAOYSA-N asaronaldehyde Natural products COC1=CC(OC)=C(C=CC=O)C=C1OC DNAVOCNYHNNEQI-UHFFFAOYSA-N 0.000 description 2
- VZPAURMDJZOGHU-SKCDSABHSA-N aurantiamide acetate Chemical compound C([C@@H](COC(=O)C)NC(=O)C(CC=1C=CC=CC=1)NC(=O)C=1C=CC=CC=1)C1=CC=CC=C1 VZPAURMDJZOGHU-SKCDSABHSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- RKFAZBXYICVSKP-UHFFFAOYSA-N beta- asarone Natural products COC1=CC(OC)=C(C=CC)C=C1OC RKFAZBXYICVSKP-UHFFFAOYSA-N 0.000 description 2
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 2
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 2
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 2
- RKFAZBXYICVSKP-WAYWQWQTSA-N beta-asarone Chemical group COC1=CC(OC)=C(\C=C/C)C=C1OC RKFAZBXYICVSKP-WAYWQWQTSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- NNWHUJCUHAELCL-UHFFFAOYSA-N cis-Methyl isoeugenol Natural products COC1=CC=C(C=CC)C=C1OC NNWHUJCUHAELCL-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 231100000895 deafness Toxicity 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 208000016354 hearing loss disease Diseases 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940116837 methyleugenol Drugs 0.000 description 2
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 2
- 201000010727 rectal prolapse Diseases 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- IPEHJNRNYPOFII-AZUAARDMSA-N sugiol Chemical compound CC([C@@H]1CC2=O)(C)CCC[C@]1(C)C1=C2C=C(C(C)C)C(O)=C1 IPEHJNRNYPOFII-AZUAARDMSA-N 0.000 description 2
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 2
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 2
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- NNWHUJCUHAELCL-SNAWJCMRSA-N trans-isomethyleugenol Chemical compound COC1=CC=C(\C=C\C)C=C1OC NNWHUJCUHAELCL-SNAWJCMRSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- CZEPBGSMIRTHKN-UHFFFAOYSA-N (+-)-Kryptojaponol Natural products O=C1CC2C(C)(C)CCCC2(C)C2=C1C=C(C(C)C)C(OC)=C2O CZEPBGSMIRTHKN-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- BUPJOLXWQXEJSQ-QLFBSQMISA-N (1r,3as,8as)-1-methyl-4-methylidene-7-propan-2-yl-2,3,3a,5,6,8a-hexahydroazulen-1-ol Chemical compound C=C1CCC(C(C)C)=C[C@@H]2[C@@](O)(C)CC[C@@H]21 BUPJOLXWQXEJSQ-QLFBSQMISA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- CZEPBGSMIRTHKN-KKSFZXQISA-N (4as,10as)-5-hydroxy-6-methoxy-1,1,4a-trimethyl-7-propan-2-yl-3,4,10,10a-tetrahydro-2h-phenanthren-9-one Chemical compound CC([C@@H]1CC2=O)(C)CCC[C@]1(C)C1=C2C=C(C(C)C)C(OC)=C1O CZEPBGSMIRTHKN-KKSFZXQISA-N 0.000 description 1
- HNOSJVWYGXOFRP-UNPOXIGHSA-N (5r,8s,9s,10s,11s,14r)-11-hydroxy-4,4,8,10,14-pentamethyl-17-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C([C@@]12C)CC(=O)C(C)(C)[C@@H]1CC[C@@]1(C)[C@H]2[C@@H](O)CC2=C([C@@H](C[C@H](O)[C@@H](O)C(C)(C)O)C)CC[C@@]21C HNOSJVWYGXOFRP-UNPOXIGHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QXTFJHAHEZDLDP-UHFFFAOYSA-N 16beta-Hydroxyalisol B monoacetate Natural products CC(CC(OC(=O)C)C1OC1(C)C)C2=C3CC(O)C4C5(C)CCC(=O)C(C)(C)C5CCC4(C)C3(C)CC2O QXTFJHAHEZDLDP-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- WCRMDMYSQWZTSF-UHFFFAOYSA-N 2-hydroxy-1-methoxy-3-methylanthracene-9,10-dione Chemical class O=C1C2=CC=CC=C2C(=O)C2=C1C=C(C)C(O)=C2OC WCRMDMYSQWZTSF-UHFFFAOYSA-N 0.000 description 1
- YJILUWQPXMLLTN-UHFFFAOYSA-N 2-methoxy-3-methylanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=C(OC)C(C)=C2 YJILUWQPXMLLTN-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- DLHXRDUXNVEIEY-UHFFFAOYSA-N 7-Methylcoumarin Chemical class C1=CC(=O)OC2=CC(C)=CC=C21 DLHXRDUXNVEIEY-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- ZDPDQMCPRXTLIP-PAPYEOQZSA-N Alismoxide Natural products CC(C)C1=C[C@H]2[C@@H](CC[C@]2(C)O)[C@](C)(O)CC1=O ZDPDQMCPRXTLIP-PAPYEOQZSA-N 0.000 description 1
- HNOSJVWYGXOFRP-UHFFFAOYSA-N Alisol A Natural products CC12CCC(=O)C(C)(C)C1CCC1(C)C2C(O)CC2=C(C(CC(O)C(O)C(C)(C)O)C)CCC21C HNOSJVWYGXOFRP-UHFFFAOYSA-N 0.000 description 1
- WXHUQVMHWUQNTG-UHFFFAOYSA-N Alisol E 24-acetate Natural products CC12CCC(=O)C(C)(C)C1CCC1(C)C2C(O)CC2=C(C(CC(O)C(OC(C)=O)C(C)(C)O)C)CCC21C WXHUQVMHWUQNTG-UHFFFAOYSA-N 0.000 description 1
- NLOAQXKIIGTTRE-JSWHPQHOSA-N Alisol b acetate Chemical compound O([C@@H]1[C@@H](OC(C)=O)C[C@@H](C)C=2CC[C@]3(C)[C@@]4(C)CC[C@H]5C(C)(C)C(=O)CC[C@]5(C)[C@@H]4[C@@H](O)CC3=2)C1(C)C NLOAQXKIIGTTRE-JSWHPQHOSA-N 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 206010056396 Asymptomatic bacteriuria Diseases 0.000 description 1
- 208000031729 Bacteremia Diseases 0.000 description 1
- 240000000724 Berberis vulgaris Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- DORJGGFFCMZTHW-KXVAGGRESA-N C[C@H](C[C@H](O)[C@H]1OC1(C)C)C1=C2C[C@H](O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1=O Chemical compound C[C@H](C[C@H](O)[C@H]1OC1(C)C)C1=C2C[C@H](O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1=O DORJGGFFCMZTHW-KXVAGGRESA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 201000007336 Cryptococcosis Diseases 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- IPEHJNRNYPOFII-UHFFFAOYSA-N DL-Sugrol Natural products O=C1CC2C(C)(C)CCCC2(C)C2=C1C=C(C(C)C)C(O)=C2 IPEHJNRNYPOFII-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- PVKQULHHWVQXLE-UHFFFAOYSA-N Glycyrol Natural products C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(O)=C(CC=C(C)C)C(OC)=C1 PVKQULHHWVQXLE-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- GFJNBLOMWYSKSS-UHFFFAOYSA-N Isoglycyrol Natural products COc1c2CCC(C)(C)Oc2cc3OC(=O)c4c(oc5c(O)cccc45)c13 GFJNBLOMWYSKSS-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- BUPJOLXWQXEJSQ-UHFFFAOYSA-N Lactifloreol Natural products C=C1CCC(C(C)C)=CC2C(O)(C)CCC21 BUPJOLXWQXEJSQ-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- MVAUGMLUJKTORM-UHFFFAOYSA-N Licoricidin Natural products COc1cc2OCC(Cc2cc1CC=C(C)C)c3ccc(O)c(CC=C(C)C)c3O MVAUGMLUJKTORM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000244939 Menispermum dauricum Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000234295 Musa Species 0.000 description 1
- 206010028470 Mycoplasma infections Diseases 0.000 description 1
- XQWFHGOIUZFQPJ-USTPAGJBSA-N Neoisoliquiritigenin Natural products O=C(/C=C/c1ccc(O)cc1)c1c(O)cc(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O2)cc1 XQWFHGOIUZFQPJ-USTPAGJBSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-LXGDFETPSA-N Neoisoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-LXGDFETPSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-UHFFFAOYSA-N Neoisoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1O)=CC=C1C(=O)C=CC1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-UHFFFAOYSA-N 0.000 description 1
- 208000000693 Neurogenic Urinary Bladder Diseases 0.000 description 1
- 206010029279 Neurogenic bladder Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- XCWPUUGSGHNIDZ-UHFFFAOYSA-N Oxypertine Chemical compound C1=2C=C(OC)C(OC)=CC=2NC(C)=C1CCN(CC1)CCN1C1=CC=CC=C1 XCWPUUGSGHNIDZ-UHFFFAOYSA-N 0.000 description 1
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 208000008718 Pyuria Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010046451 Urethral fistula Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 206010047400 Vibrio infections Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- KOOCQNIPRJEMDH-QSKXMHMESA-N [(1S,3R)-1-[(2R)-3,3-dimethyloxiran-2-yl]-3-[(5R,8S,9S,10S,11S,14R)-11-hydroxy-4,4,8,10,14-pentamethyl-3,16-dioxo-2,5,6,7,9,11,12,15-octahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl] acetate Chemical compound C[C@H](C[C@H](OC(C)=O)[C@H]1OC1(C)C)C1=C2C[C@H](O)[C@H]3[C@@]4(C)CCC(=O)C(C)(C)[C@@H]4CC[C@]3(C)[C@@]2(C)CC1=O KOOCQNIPRJEMDH-QSKXMHMESA-N 0.000 description 1
- WXHUQVMHWUQNTG-JSWHPQHOSA-N [(3r,4s,6r)-2,4-dihydroxy-6-[(5r,8s,9s,10s,11s,14r)-11-hydroxy-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-yl] acetate Chemical compound C([C@@]12C)CC(=O)C(C)(C)[C@@H]1CC[C@@]1(C)[C@H]2[C@@H](O)CC2=C([C@@H](C[C@H](O)[C@@H](OC(C)=O)C(C)(C)O)C)CC[C@@]21C WXHUQVMHWUQNTG-JSWHPQHOSA-N 0.000 description 1
- NLOAQXKIIGTTRE-CXWFPJGHSA-N [1-(3,3-dimethyloxiran-2-yl)-3-[(8s,10s,11s,14r)-11-hydroxy-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]butyl] acetate Chemical compound C([C@]1(C)[C@@]2(C)CCC3C(C)(C)C(=O)CC[C@]3(C)C2[C@@H](O)CC1=1)CC=1C(C)CC(OC(C)=O)C1OC1(C)C NLOAQXKIIGTTRE-CXWFPJGHSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- MDWXTAJJDBSNKM-KKUMJFAQSA-N alismol Natural products CC(C)C1=CC[C@H]2[C@@H](CC[C@]2(C)O)C(=C)C1 MDWXTAJJDBSNKM-KKUMJFAQSA-N 0.000 description 1
- QMCLOHXDDPMAMI-UHFFFAOYSA-N alisol B Natural products CC(C)C(=O)C(O)CC(C)C1=C2CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC1 QMCLOHXDDPMAMI-UHFFFAOYSA-N 0.000 description 1
- DORJGGFFCMZTHW-UHFFFAOYSA-N alisol C Natural products C=12CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC(=O)C=1C(C)CC(O)C1OC1(C)C DORJGGFFCMZTHW-UHFFFAOYSA-N 0.000 description 1
- KOOCQNIPRJEMDH-UHFFFAOYSA-N alisol C monoacetate Natural products C=12CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC(=O)C=1C(C)CC(OC(C)=O)C1OC1(C)C KOOCQNIPRJEMDH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- PSVBPLKYDMHILE-UHFFFAOYSA-N alpha-humulene Natural products CC1=C/CC(C)(C)C=CCC=CCC1 PSVBPLKYDMHILE-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- IBIPGYWNOBGEMH-DILZHRMZSA-N asperuloside Chemical compound O([C@@H]1OC=C2C(=O)O[C@H]3C=C([C@@H]1[C@H]32)COC(=O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBIPGYWNOBGEMH-DILZHRMZSA-N 0.000 description 1
- COUXBBBIXWWAEP-AGUBZPQCSA-N asperuloside Natural products CC(=O)OCC1=C[C@@H]2OC(=O)C3=CO[C@@H](OC[C@H]4O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]4O)[C@H]1[C@H]23 COUXBBBIXWWAEP-AGUBZPQCSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- FDABVSXGAMFQQH-XZWHSSHBSA-N berbamunine Chemical compound CN1CCC2=CC(OC)=C(O)C=C2[C@H]1CC1=CC=C(O)C(OC2=CC=C(C=C2)C[C@@H]2N(C)CCC=3C=C(C(=CC=32)O)OC)=C1 FDABVSXGAMFQQH-XZWHSSHBSA-N 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- LWESBHWAOZORCQ-UHFFFAOYSA-N glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CC=C(C)C)C(O)=C1 LWESBHWAOZORCQ-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 229940124589 immunosuppressive drug Drugs 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- CFWLRXJPRRCJTI-UHFFFAOYSA-N iso-glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CCC(C)(C)O2)C2=C1 CFWLRXJPRRCJTI-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- GBRZTUJCDFSIHM-KRWDZBQOSA-N licoricidin Chemical compound C1([C@@H]2COC=3C=C(O)C(CC=C(C)C)=C(C=3C2)OC)=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-KRWDZBQOSA-N 0.000 description 1
- GBRZTUJCDFSIHM-UHFFFAOYSA-N licorisoflavan B Natural products C1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OCC1C1=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000003236 psychic effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000005181 root of the tongue Anatomy 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 210000003741 urothelium Anatomy 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of eliminating inflammation and expelling toxin diuresis soup, the raw medicinal material of use is respectively:17 parts of rhizoma alismatis, 35 parts of rhizoma imperatae, 15 parts of Cortex Phellodendri, 20 parts of dandelion, 15 parts of garden burnet, 20 parts of the root bark of Chinese wolf-berry, 20 parts of radix bupleuri, 20 parts of plantain seed, 35 parts of oldenlandia diffusa, 20 parts of, Bi Collettiis, 20 parts of grass-leaved sweetflag, 15 parts of radix achyranthis bidentatae, 35 Fen, pivots of desmodium store 35 parts, 6 parts of Radix Glycyrrhizae.Present invention relates particularly to a kind of eliminating inflammation and expelling toxin diuresis soup, and it is with obvious effects to be suitable for urinary tract infections, chronic and refractory urinary tract infections with clearing heat and cooling blood, anti-inflammatory diuresis, effect that removing toxic substances is treating stranguria.
Description
Technical field
The present invention relates to the field of Chinese medicines, and in particular to a kind of eliminating inflammation and expelling toxin diuresis soup, have clearing heat and cooling blood, anti-inflammatory diuresis,
Detoxify treating stranguria effect, it is with obvious effects to be suitable for urinary tract infections, chronic and refractory urinary tract infections.
Background technology
Urinary tract infections is also known as urinary system infection contamination, is inflammatory reaction caused by urothelium invades bacterium, usually adjoint
There are bacteruria and pyuria.95% or more urinary tract infections is caused by single bacterium.Wherein 90% outpatient and 50% or so live
Institute patient, pathogen are Escherichia coli, this bacterium serotype causes urine sense type Escherichia coli and disease up to 140 kinds
The Escherichia coli separated in human faecal mass belongs to same bacterial type, is more common in asymptomatic bacteriuria or the sense of uncomplicated urine;
The white pneumobacillus of proteus, aerobacteria, Cray, pseudomonas aeruginosa, streptococcus fecalis etc. see infect again, indwelling catheter
Manage, have the urinary tract infections person of complication;Candida albicans, C. neoformans infection are more common in diabetes and use glucocorticoid
After the patient of immunosuppressive drug and kidney transplant;Staphylococcus aureus is more common in bacteremia caused by skin trauma and drug addict
And septicemia;Though virus, mycoplasma infection category are rare, have gradually increase trend in recent years.Various bacteria infection sees indwelling and leads
Urinary catheter, neurogenic bladder, calculus, congenital abnormality and vagina, enteron aisle, urethral fistula etc..
Invention content
The purpose of the present invention is to provide a kind of eliminating inflammation and expelling toxin diuresis soup, and with clearing heat and cooling blood, anti-inflammatory diuresis, removing toxic substances is treating stranguria
The effect of, it is with obvious effects to be suitable for urinary tract infections, chronic and refractory urinary tract infections.
The technical solution adopted by the present invention is:
The eliminating inflammation and expelling toxin diuresis soup, the raw medicinal material of use are respectively:17 parts of rhizoma alismatis, 35 parts of rhizoma imperatae, 15 parts of Cortex Phellodendri, Pu Gong
20 parts of English, 15 parts of garden burnet, 20 parts of the root bark of Chinese wolf-berry, 20 parts of radix bupleuri, 20 parts of plantain seed, 35 parts of oldenlandia diffusa, 20 parts of, Bi Collettiis, grass-leaved sweetflag
20 parts, 15 parts of radix achyranthis bidentatae, 35 Fen, pivots of desmodium store 35 parts, 6 parts of Radix Glycyrrhizae.
Preparation method is for following steps:Step 1), weigh raw medicinal material:17 parts of rhizoma alismatis, 35 parts of rhizoma imperatae, Cortex Phellodendri
15 parts, 20 parts of dandelion, 15 parts of garden burnet, 20 parts of the root bark of Chinese wolf-berry, 20 parts of radix bupleuri, 20 parts of plantain seed, 35 parts of, Bi Collettiis 20 of oldenlandia diffusa
Part, 20 parts of grass-leaved sweetflag, 15 parts of radix achyranthis bidentatae, 35 Fen, pivots of desmodium store 35 parts, 6 parts of Radix Glycyrrhizae, remove impurity, rapid with cold boiled water water
It eluriates, drains aqueous, dry;
Step 2), step 1)Medicine materical crude slice is respectively prepared in obtained raw medicinal material, sets suitable in decocting device, addition clear water is appropriate, leaching
Suitable time is steeped, is heated to boiling, is kept for slight boiling condition certain time(About 1.5 ~ 2 hours), detach fried liquid;
Step 3), step 2)It obtains the filtered dregs of a decoction and adds water appropriate decoction, after being decocted 2 ~ 3 times by regulation, merge
Fried liquid, filtering or the fried liquid of sedimentation separation;
Step 4), step 3)Obtained Chinese medicine preparation is sealed packaging, obtains commodity Chinese medicine preparation.
In the raw medicinal material that the present invention chooses, effect and pharmacological action are respectively:
Rhizoma alismatis:Nature and flavor:It is sweet, it trembles with fear.Channel tropism:Enter kidney, bladder warp.Effect:Li Shui, excreting dampness expel the heat-evil.Control difficult urination, oedema turgor,
Vomiting, rush down dysentery, phlegm and retained fluid, tinea pedis, gonorrhoea, hematuria.Chemical composition:Stem tuber, which contains, rushes down alcohol(alisol)A, B, C, alisol A list acetic acid
Ester(alisol A monoacetate), Alisol B 23-monoacetate(alisol B monoacetate), the mono- acetic acid of alisol C
Vinegar(alisol C monoacetate)Table alisol(epialisol)A, rhizoma alismatis Azulene alcohol(alismol), rhizoma alismatis Azulene alcohol oxide
(alismoxide), 16 'beta '-methoxy Alisol B 23-monoacetates(16β-methocyal-isol B monoacetate), 16 β-
Hydroxyl Alisol B 23-monoacetate(16β-hydroxyal-isol B monoacetate), sitosterol -3-O- stearyls -
β-D- glucopyanosides(sitosterol-3-O-steroyl-β-D-glucopyranoside).Also contain choline(cho-
line), the elements such as sugar and potassium, calcium, magnesium.
Rhizoma imperatae:Nature and flavor:Sweet-bitter flavor, it is cold in nature, it is nontoxic;It cures mainly:Cooling blood and hemostasis, it is clearing heat and detoxicating.For spitting blood, hematuria, heat
Leaching, oedema, jaundice, difficult urination, pyreticosis polydipsia, stomach hot vomiting, cough;Deficiency-cold in spleen and stomach, more not thirsty persons that urinate avoid clothes.
Cortex Phellodendri:【Meridian distribution of property and flavor】Hardship is trembled with fear.Return kidney, bladder, large intestine channel.【Function with cure mainly】Heat-clearing and damp-drying drug, purging intense heat and detonicating,
Except hectic fever due to yin clearind deficient heat.For damp-heat dysentery, jaundice, under band, heat gonorrhea, tinea pedis, impotence wards off, hectic fever due to yin labor heat, night sweat, seminal emission, and sore is swollen
Poison, eczema itch.Stir-baked CORTEX PHELLODENDRI with salt solution nourishing yin and lessening fire.For fire excess from yin deficiency, night sweat hectic fever due to yin.【Chemical composition】CORTEX PHELLODENDRI AMURENE mainly contains barberry
Alkali about 1.6% still contains palmatine, phellodendrine, jateorrhizine, obakunone, menispermum dauricum and appoints alkali, candicine, magnoline, lemon
The root skins such as lemon bitter principle isolate jamaicin about 9%, still contain jateorrhizine, phellodendrine, candicine;CORTEX PHELLODENDRI CHINENSE content of berberine compared with
Height, up to 3%;【Antibacterial action】Cortex Phellodendri antibiotic effective ingredient is jamaicin Cortex Phellodendris decoction or alcohol preserved material in vitro test to golden yellow
Staphylococcus, staphylococcus albus, Staphylococcus citreus, Diplococcus pneumopniae, diplococcus meningitidis, Streptococcus viridans, suddenly
Random vibrios, corynebacterium diphtheriae, shigella dysenteriae, Pseudomonas aeruginosa etc. have inhibiting effect, almost to Escherichia coli Radix Salviae Miltiorrhizae, typhoid bacillus
In vain.
Dandelion:【Nature,taste and action】:Sweet, slight bitter is trembled with fear.It is clearing heat and detoxicating, dispersing swelling and dissipating binds.【It cures mainly】:The infection of the upper respiratory tract, eye
Conjunctivitis, mumps, hyperglycemia, acute mastitis swelling and pain, gastritis, dysentery, hepatitis, chrysanthemum inflammation, acute appendicitis, urinary system sense
Dye, pelvic infecton, carbuncle boils boils, pharyngitis control acute mastitis, adenolymphitis, scrofula, boil poisonous soreness, acute conjunctivitis, flu hair
Heat, acute tonsillitis, acute bronchitis, urinary tract infections.Containing taraxasterol(Taraxasterol), choline
(Choline), synanthrin(Inulin), pectin(Pectin);Taraxol(Taraxol), stigmasterol(Stigmasterol)、β-
Amyrin(β-Amyrin), cupreol(β-Sitosterol), taraxerol(taraxerol), taraxacin
(Taraxacerin), taraxacin(Taraxacin)With vitamin A, B, C etc..
Garden burnet:【Meridian distribution of property and flavor】Picric acid;It is cold;It is nontoxic.Return liver;Lung;Kidney;Large intestine channel.【Effect】Cooling blood and hemostasis, heat-clearing
Removing toxic substances, healing up sore and subduing swelling.It spits blood, spitting of blood, bleeding from five sense organs or subcutaneous tissue, hematuria is had blood in stool, hemorrhoid blood, bloody flux, uterine bleeding, leukorrhea with reddish discharge, sore, carbuncle and painful swelling, eczema,
Pruritus vulvae, scald, snakebite and bugbite.【Pharmacological action】1, astriction garden burnet contains tannin, has astriction, can antidiarrheal
And hemostasis.2. antibacterial action experiment in vitro proves:The decocting liquid of garden burnet 100% is to typhoid bacillus, diplococcus meningitidis, Fu Shi dysentery
Shigella, bacterium sonnei, beta hemolytic streptococcus, staphylococcus aureus, Diplococcus pneumopniae, corynebacterium diphtheriae, large intestine
Bacillus, hay bacillus, typhoid bacillus, paratyphosum Bacterium, Pseudomonas aeruginosa, comma bacillus and Bacillus tuberculosis have in various degree
Inhibiting effect.
The root bark of Chinese wolf-berry:Chemical composition:Root skin contains glycine betaine(betaine), lyciumamide(lyciumamide), cupreol,
Cryptojaponol(sugiol), Melissic Acid(melissic acid), linoleic acid and cinnamic acid.Nature and flavor:It is cold in nature, it is sweet in flavor.Major function:
Cool blood is except steaming, clearing lung-heat fall fire.For deficiency of Yin hectic fever, hectic fever due to yin night sweat, cough with lung heat, spitting of blood, bleeding from five sense organs or subcutaneous tissue.
Radix bupleuri:Clearind deficient heat Chinese medicine, for cold, fever, fevers and chills alternate, malaria, stagnation of QI due to depression of the liver, sternal rib pain, rectal prolapse, son
Palace falls off, irregular menstruation.Meridian distribution of property and flavor:Cold nature, bitter, pungent, return liver warp, lung channel, the spleen channel.Function:Saturating table expels the heat-evil, soothing the liver solution
It is strongly fragrant, it rises and lifts yang-energy.It cures mainly:Cold, fever, fevers and chills alternate, malaria, stagnation of QI due to depression of the liver, sternal rib pain, rectal prolapse, uterus fall off, menstruation
It is uncomfortable.
Plantain seed:Nature and flavor:It is sweet;It is light;Cold nature.Channel tropism:It is distributed in lung channel;Liver Channel;Kidney channel;Bladder warp.Function:Reducing fever and causing diuresis;
Excreting dampness antidiarrheal;Improving eyesight;Eliminating the phlegm.It cures mainly:Main difficult urination;Under stranguria with turbid discharge band;Oedema turgor;Summer-heat and damp rush down dysentery;Hot eyes is hidden from view;Phlegm heat-syndrome cough
Asthma.
Oldenlandia diffusa:Chemical composition:Herb contains asperuloside, and asperuloside acid removes acetic acid, base asperuloside acid, all
Square rafter glucoside acid, Chinese Fevervine Herb time glucoside, Chinese Fevervine Herb time glucoside methyl esters, 6-O- p- hydroxyl cinnamyl Chinese Fevervine Herb time glucoside methyl esters, the p- first of 6-O-
Oxygroup cinnamyl Chinese Fevervine Herb time glucoside methyl esters, 6-O- asafoetide acyls Chinese Fevervine Herb time glucoside methyl esters, 2- methyl -3- hydroxy-anthraquiones, 2- methyl -3-
Methoxy anthraquinone, 2- methyl -3- hydroxyl -4- methoxy anthraquinones etc. and ursolic acid, cupreol, hentriacontane, stigmasterol,
Oleanolic acid, cupreol-β-glycoside, p-coumaric acid etc..It cures mainly:Dyspnea and cough due to lung-heat;Abscess of throat;Acute appendicitis;Furuncle sore
Ulcer;Venomous snake bite;Puckery pain of heat gonorrhea;Oedema;Dysentery;Enteritis;Jaundice with damp-heat pathogen;It is good at a variety of cancerous swellings for the treatment of.Nature and flavor:Bitter, light, property
It is cold.
Bi Collettii:【Nature and flavor】:It is mild-natured, bitter;【Channel tropism】:Enter Liver Channel, stomach, bladder warp.【Function】:Dampness removing goes turbid, wind-dispelling
Logical numbness.Dampness removing removes turbid, wind expelling stagnation removing.【It cures mainly】:It is drenched for cream, gonorrhoea, leukorrhea, arthralgia pain due to rheumatism, articular instability, waist and knee pain
Bitterly.
Grass-leaved sweetflag:(It is pungent, bitter, temperature.The thoughts of returning home, stomach.Dampness elimination appetizing, slit phlegm of having one's ideas straightened out, inducing resuscitation intelligence development.For gastral cavity ruffian is not hungry, keep silent
Mouth diarrhea, coma epilepsy, forgetfulness and deafness.Qi-regulating, promoting blood circulation, relieve heat are dried.Control epilepsy, coma due to blocking of the respiratory system, pyreticosis coma, forgetful, psychic deafness
Deaf, ambition is unhappy, stomachache, abdominal pain, wind-cold-dampness arthralgia, swollen ulcer drug, traumatic injury.Rhizome and Ye Zhongjun contain volatile oil(0.11%~
0.42%)And carbohydrate, organic acid, amino acid etc..Contain 34 kinds of ingredients in volatile oil, main component is beta-Asarone(β-
Asarone), account for 63.2%~81.2%;α-asarone(α-Asarone), account for 3.4%~13.7%;Secondly it is carypohyllene
(Caryophyllene), α-Humuleno(α-Humulene), sekishone(Sekishone), asarylaldehyde
(Asarylaldehyde), elemicin(Elemicine), euasarone(Euasarone), 1- allyl -2,4,5- trimethoxies
Base benzene(1-Allyl-2,4,5-trimethoxy benzene), methyleugenol(Methyleugenol), cis- methyl it is different
Eugenol, transmethyl isoeugenol(trans-Methylisoeugenol)Deng.
Radix achyranthis bidentatae:Major function:Internal heat anticance;It is promoting blood circulation and removing blood stasis;By silt eliminating impediment;Anti-inflammatory diuresis;Purify the blood disinfection;Scattered blood stops
Bitterly.
Desmodium:With clearing heat and detoxicating, eliminating stasis to subdue swelling, the effect of removing dampness through diuresis and removing jaundice, expelling wind and clearing away cold, it can be used for cold cough,
Body of having a headache aches, diarrhea, heat gonorrhea, Sha Lin, and urine is puckery to have a pain, jaundice, carbuncle swells furunculosis, venomous snake bite, liver and bile stone, lithangiuria
Equal diseases.Meridian distribution of property and flavor:Property is sweet;Slight bitter;It is cool in nature;Return liver;Courage;Kidney;Bladder warp.
Pivot stores:Hardship is slightly cold.Return bladder warp.The product hardship falls row, tonneau bladder, it is bitter dry and can desinsection removing dampness to relieve itching, mainly
For drenching pain and eczema.Promoting diuresis for stranguria is used for damp-heat gonorrhoea, can treat urinary infection, calculus, blood urine etc..Desinsection is antipruritic,
The parasitic diseases such as pinworm can be treated.It also can decoction washout treatment skin sore rash, itch.
Radix Glycyrrhizae:It is mild-natured, it is sweet in flavor.Major function:It invigorates the spleen and benefits qi, clearing heat and detoxicating, expelling phlegm and arresting coughing,Relieving spasm to stop pain, coordinating the drug actions of a prescription.
ForIt is weakness of the spleen and the stomach, lassitude hypodynamia, palpitation, coughAbundant expectoration, gastral cavity abdomen,Four limbsContraction urgency pain,Carbuncle swellsSore alleviates drug poison
It is property, strong.Chemical composition:Radix Glycyrrhizae contains there are many chemical composition, and main component has glycyrrhizic acid, liquiritin etc..It is detached from Radix Glycyrrhizae
The compound gone out has glycyrrhizin, enoxolone, liquiritin, isoliquiritin, neoliquriitin, neoisoliquiritin, glycyrrhizin, different sweet
The tens of kinds of compounds such as careless element and licoricidin, glycyrol, isoglycyrol, 7- methylcoumarins essence, umbelliferone.
The present invention has clearing heat and cooling blood, anti-inflammatory diuresis, effect that removing toxic substances is treating stranguria, is suitable for urinary tract infections, chronic and refractory
Urinary tract infections is with obvious effects.The effect of Chinese medicine preparation of the present invention confirmed in clinical application, clinical test of pesticide effectiveness material
Material and model case:
1. Lee XX, female, 45 years old.On June 11st, 2002 is medical.Main suit's difficult urination is more than January.The end of last month, unexpected urgent urination, urinated
Frequently, urethral fever pain, underbelly arrested anxious, distending pain tenesmus, the tired pain of waist, urine color are yellow.Come to see a doctor, check:Patient's eyelid and lower limb
Softness edema.Red tongue body, root of the tongue portion yellow and greasy fur, slippery and rapid pulse.Diagnosis:Urinary tract infections.It controls with clearing heat and cooling blood, anti-inflammatory diuresis, removing toxic substances
Treating stranguria method.After taking 7 doses of the present invention, urethral fever pain, cramping sensation of the lower abdomen pendant pain disappears, and remaining disease mitigates, and only takes still pain, yellowish fur and subtracts
Few, slippery continues after taking 7 doses of we, and symptom disappears, and recovers.
Method and effective quantity:17 parts of rhizoma alismatis, 35 parts of rhizoma imperatae, 15 parts of Cortex Phellodendri, 20 parts of dandelion, 15 parts of garden burnet, the root bark of Chinese wolf-berry
20 parts, 20 parts of radix bupleuri, 20 parts of plantain seed, 35 parts of oldenlandia diffusa, 20 parts of, Bi Collettiis, 20 parts of grass-leaved sweetflag, 15 parts of radix achyranthis bidentatae, desmodium
35 Fen, pivots store 35 parts, 6 parts of Radix Glycyrrhizae.
Preparation method is for following steps:Step 1), weigh raw medicinal material:17 parts of rhizoma alismatis, 35 parts of rhizoma imperatae, Cortex Phellodendri
15 parts, 20 parts of dandelion, 15 parts of garden burnet, 20 parts of the root bark of Chinese wolf-berry, 20 parts of radix bupleuri, 20 parts of plantain seed, 35 parts of, Bi Collettiis 20 of oldenlandia diffusa
Part, 20 parts of grass-leaved sweetflag, 15 parts of radix achyranthis bidentatae, 35 Fen, pivots of desmodium store 35 parts, 6 parts of Radix Glycyrrhizae, remove impurity, rapid with cold boiled water water
It eluriates, drains aqueous, dry;
Step 2), step 1)Medicine materical crude slice is respectively prepared in obtained raw medicinal material, sets suitable in decocting device, addition clear water is appropriate, leaching
Suitable time is steeped, is heated to boiling, is kept for slight boiling condition certain time(About 1.5 ~ 2 hours), detach fried liquid;
Step 3), step 2)It obtains the filtered dregs of a decoction and adds water appropriate decoction, after being decocted 2 ~ 3 times by regulation, merge
Fried liquid, filtering or the fried liquid of sedimentation separation;
Step 4), step 3)Obtained Chinese medicine preparation is sealed packaging, obtains commodity Chinese medicine preparation.
It based on decoction oral, daily 1 dose, is decocted in water for oral dose, early, evening respectively takes 1 time, and each 110ml warmly takes.
Specific implementation mode
Eliminating inflammation and expelling toxin diuresis soup of the present invention, the raw medicinal material of use are respectively:17 parts of rhizoma alismatis, 35 parts of rhizoma imperatae, Huang
35 parts of 15 parts of cypress, 20 parts of dandelion, 15 parts of garden burnet, 20 parts of the root bark of Chinese wolf-berry, 20 parts of radix bupleuri, 20 parts of plantain seed, oldenlandia diffusa, Bi Collettiis
20 parts, 20 parts of grass-leaved sweetflag, 15 parts of radix achyranthis bidentatae, 35 Fen, pivots of desmodium store 35 parts, 6 parts of Radix Glycyrrhizae.
Preparation method is for following steps:Step 1), weigh raw medicinal material:17 parts of rhizoma alismatis, 35 parts of rhizoma imperatae, Cortex Phellodendri
15 parts, 20 parts of dandelion, 15 parts of garden burnet, 20 parts of the root bark of Chinese wolf-berry, 20 parts of radix bupleuri, 20 parts of plantain seed, 35 parts of, Bi Collettiis 20 of oldenlandia diffusa
Part, 20 parts of grass-leaved sweetflag, 15 parts of radix achyranthis bidentatae, 35 Fen, pivots of desmodium store 35 parts, 6 parts of Radix Glycyrrhizae, remove impurity, rapid with cold boiled water water
It eluriates, drains aqueous, dry;
Step 2), step 1)Medicine materical crude slice is respectively prepared in obtained raw medicinal material, sets suitable in decocting device, addition clear water is appropriate, leaching
Suitable time is steeped, is heated to boiling, is kept for slight boiling condition certain time(About 1.5 ~ 2 hours), detach fried liquid;
Step 3), step 2)It obtains the filtered dregs of a decoction and adds water appropriate decoction, after being decocted 2 ~ 3 times by regulation, merge
Fried liquid, filtering or the fried liquid of sedimentation separation;
Step 4), step 3)Obtained Chinese medicine preparation is sealed packaging, obtains commodity Chinese medicine preparation.
Claims (2)
1. a kind of eliminating inflammation and expelling toxin diuresis soup, which is characterized in that the raw medicinal material of use is respectively:17 parts of rhizoma alismatis, 35 parts of rhizoma imperatae,
15 parts of Cortex Phellodendri, 20 parts of dandelion, 15 parts of garden burnet, 20 parts of the root bark of Chinese wolf-berry, 20 parts of radix bupleuri, 20 parts of plantain seed, 35 parts of oldenlandia diffusa, Bi
20 parts of Collettii, 20 parts of grass-leaved sweetflag, 15 parts of radix achyranthis bidentatae, 35 Fen, pivots of desmodium store 35 parts, 6 parts of Radix Glycyrrhizae.
2. eliminating inflammation and expelling toxin diuresis soup according to claim 1, it is characterised in that:Preparation method, preparation method be for
Lower step:
Step 1), weigh raw medicinal material:17 parts of rhizoma alismatis, 35 parts of rhizoma imperatae, 15 parts of Cortex Phellodendri, 20 parts of dandelion, 15 parts of garden burnet,
20 parts of bone skin, 20 parts of radix bupleuri, 20 parts of plantain seed, 35 parts of oldenlandia diffusa, 20 parts of, Bi Collettiis, 20 parts of grass-leaved sweetflag, 15 parts of radix achyranthis bidentatae, gold
Money 35 Fen, pivots of grass store 35 parts, 6 parts of Radix Glycyrrhizae, remove impurity, are eluriated rapidly with cold boiled water water, drain aqueous, dried;
Step 2), step 1)Medicine materical crude slice is respectively prepared in obtained raw medicinal material, sets suitable in decocting device, addition clear water is appropriate, leaching
Suitable time is steeped, is heated to boiling, is kept for slight boiling condition certain time(About 1.5 ~ 2 hours), detach fried liquid;
Step 3), step 2)It obtains the filtered dregs of a decoction and adds water appropriate decoction, after being decocted 2 ~ 3 times by regulation, merge
Fried liquid, filtering or the fried liquid of sedimentation separation;
Step 4), step 3)Obtained Chinese medicine preparation is sealed packaging, obtains commodity Chinese medicine preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710074894.2A CN108420952A (en) | 2017-02-13 | 2017-02-13 | Eliminating inflammation and expelling toxin diuresis soup |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710074894.2A CN108420952A (en) | 2017-02-13 | 2017-02-13 | Eliminating inflammation and expelling toxin diuresis soup |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108420952A true CN108420952A (en) | 2018-08-21 |
Family
ID=63147203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710074894.2A Pending CN108420952A (en) | 2017-02-13 | 2017-02-13 | Eliminating inflammation and expelling toxin diuresis soup |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108420952A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117665191A (en) * | 2023-12-07 | 2024-03-08 | 唐宁医药科技(济南)有限公司 | Method for detecting quality of effective components in known cellulitis particles |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104324257A (en) * | 2014-10-17 | 2015-02-04 | 王怀喜 | Traditional Chinese medicine preparation for treating cystitis |
-
2017
- 2017-02-13 CN CN201710074894.2A patent/CN108420952A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104324257A (en) * | 2014-10-17 | 2015-02-04 | 王怀喜 | Traditional Chinese medicine preparation for treating cystitis |
Non-Patent Citations (1)
Title |
---|
隋殿军 等: "《国家级名医秘验方》", 31 July 2016, 吉林科学技术出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117665191A (en) * | 2023-12-07 | 2024-03-08 | 唐宁医药科技(济南)有限公司 | Method for detecting quality of effective components in known cellulitis particles |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101804166B (en) | Traditional Chinese medicine composition for treating dermatitis and eczema of infants | |
CN102205026B (en) | Chinese medicinal composition for treating children chronic sinusitis and preparation method thereof | |
CN105535715A (en) | Traditional Chinese medicine skin-wash liquid for treating hot and damp eczema | |
CN102178814B (en) | Chinese medicinal composition for treating trichomonas vaginitis and preparation method thereof | |
CN101518600B (en) | Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof | |
CN106804643A (en) | A kind of clinical laboratory Chinese medicine sterilizing thimerosal | |
CN104288504A (en) | Traditional Chinese medicinal ointment preparation for treating burn and scalds and preparation method thereof | |
CN103239662B (en) | Parasite expelling Chinese herbal preparation for animals | |
CN106806758A (en) | A kind of Chinese medicine preparation for treating acne | |
CN109549958B (en) | Composition for treating hormone-dependent dermatitis and preparation method thereof | |
CN103721138B (en) | A kind of traditional Chinese medicine for external application and its preparation method treating rosacea | |
CN106237247A (en) | A kind of Chinese medicine composition treating gynecological inflammation | |
KR101125758B1 (en) | A detergent composition for cleaning the women's genital area | |
CN108420952A (en) | Eliminating inflammation and expelling toxin diuresis soup | |
CN104383203A (en) | Traditional Chinese medicine preparation for treating pelvic inflammation | |
CN103845616A (en) | Pharmaceutical composition for eliminating inflammation and disinfecting | |
CN104491825B (en) | A kind of Chinese medicine ointment for the treatment of oral ulcer | |
CN102274420A (en) | Chinese medicinal composition for treating acnes | |
CN113181318A (en) | Traditional Chinese medicine ointment for treating haemorrhoids and preparation method thereof | |
CN105709101A (en) | Traditional Chinese medicine preparation for treating blepharitis ciliaris and preparation method thereof | |
CN104958757A (en) | Pressure sore paste and preparation method thereof | |
CN105012580A (en) | Perineum care solution | |
CN106110193A (en) | A kind of external skin ulcer convergence ointment and compound method thereof | |
CN103860976A (en) | Drug composition for treating infantile dermatitis | |
CN105079337A (en) | Care solution for preventing bed sore and preparation method therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180821 |